Nearly 170 million years of healthy life lost due to cancer in 2008

October 15, 2012

The first detailed study to estimate the global impact of cancer on the number of healthy years of life lost by patients has revealed that nearly 170 million years of healthy life were lost because of cancer in 2008, according to an article published Online First in the Lancet.

The study used a measure known as disability-adjusted life-years (DALYs) to take account of not only the effects of fatal cancer, but also the effects of disabling non-fatal disease outcomes (e.g. for or infertility for cervical cancer). The researchers analysed data from the cancer registries worldwide to estimate that globally, 169.3 million years of healthy life were lost due to cancer in 2008.

According to lead author Dr Isabelle Soerjomataram, at the International Agency for Research on Cancer (IARC) in Lyon, France, "While overall DALYs are remarkably similar across different levels of human development*, they reflect a higher average in lower income countries and a higher average disability and impairment in higher income countries. Our study represents an important first step towards establishing an evidence base for fatal and non-fatal cancer-related outcomes that is urgently needed to set priorities in ."

Dr Freddie Bray, one of the paper's co-authors and Deputy Head of the IARC's Section of , adds "Our findings illustrate quite starkly how cancer is already a barrier to sustainable development in many of the poorest countries across the world and this will only be exacerbated in the coming years if cancer control is neglected."

Asia and Europe were the main contributors to the global burden of years of lost due to cancer, with men in eastern Europe facing the largest cancer burden worldwide (3146 age-adjusted DALYs lost per 100 000 men). For women, the highest burden was found in sub-Saharan Africa (2749 age-adjusted DALYs lost per 100 000 women).

Colorectal, lung, breast, and were the main contributors to total DALYs rates in most regions, accounting for 18 – 50% of the total cancer burden. The contribution of infection-related cancers to the overall DALYs (primarily liver, stomach, and ) was high in Sub-Saharan Africa (25% of all cancers) and eastern Asia (27% of all cancers), compared to other regions.

The study also highlights the fact that improved access to high-quality treatment has not greatly improved survival for a number of common cancers associated with poor prognoses (especially lung, stomach, liver, and pancreatic cancers), emphasising the crucial role that primary prevention will need to play if the global cancer burden is to be reduced.

Writing in a linked Comment, Dr Ahmedin Jemal, at the American Cancer Society in Atlanta, USA, outlines the difference between the measure used in this study and other commonly used measures: "By contrast with mortality rates and counts, which emphasise deaths occurring at old ages, DALY give more weight to deaths occurring at young ages at which people are more likely to be working, raising children, and supporting other family members."

However, Dr Jemal points out that addressing the challenges highlighted by the new study will require a major effort, adding that, "Implementation of comprehensive and sustainable interventions to challenge the growing burden in low-income and middle-income countries will require the coordinated efforts of many stakeholders from the public and private sectors, including national and international public health agencies, health industries, philanthropic and government donors, and local and regional policy makers."

Explore further: Cancer incidence predicted to increase 75 percent by 2030

More information: * The researchers grouped estimates of DALYs into four categories, based on countries' Human Development Index (HDI). HDI combines indicators of life expectancy, educational attainment and income, allowing human development to be compared between countries.

Paper online: www.thelancet.com/journals/lan … (12)60919-2/abstract

Related Stories

Cancer incidence predicted to increase 75 percent by 2030

May 31, 2012
The global cancer burden is set to surge more than 75% by 2030, according to new research published Online First in the Lancet Oncology. The rise is predicted to be even larger in the developing world, with the poorest countries ...

One in six cancers worldwide caused by infections that are largely preventable or treatable

May 8, 2012
Infectious agents cause around 2 million new cancer cases a year worldwide, of which 80% occur in less developed regions, according to new estimates published Online First in The Lancet Oncology. Of the 7.5 million deaths ...

Lifestyle changes can help prevent 30% of cancers: WHO

February 3, 2012
More than 30 percent of cancers can be prevented by lifestyle changes, the World Health Organization said Friday, on the eve of World Cancer Day.

Cancer mortality rates are higher in men than women

July 12, 2011
Overall cancer mortality rates are higher for men than women in the United States, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.